ArticleBrain sciences2026

Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status.

Flavio Donnini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.